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A multifunctional nanocarrier based on cystamine (Cys) and β-cyclodextrin (β-CD) 
modified graphene oxide (GO) was designed for targeted delivery of Doxorubicin 
(DOX). The obtained CD-Cys-GO nanosheet was characterized by thermogravimetric 
analysis, Fourier transform infrared spectroscopy, Raman  spectroscopy, Atomic force 
microscopy and Field emission scanning electron microscopy, which confirmed that 
Cys and CD had been effectively functionalized on the surface of GO. DOX loading 
and delivery were also examined and the results suggested that multi-functionalized 
GO is an efficient nanocarrier for targeted delivery and controlled release of anticancer 
drug for biomedical applications. 
Introduction: Graphene oxide (GO) based drug carriers have been introduced as an 
important topic of research at the interface of nanotechnology and biomedicine due to 
their high specific surface area, enriched oxygen-containing groups, low cost and 
scalable production, excellent biocompatibility, and physiological stability. 
Cyclodextrin (CD) is a cyclic oligomer which its biological nature makes it attractive 
in pharmaceutical field. Moreover, the hydrophobic cavity of CD can selectively bind 
various organic, inorganic and biological molecules to form supramolecular complexes 
without structural changes. 
Methods and Results: In this research, GO nanosheet was synthesized according to 
Hummer’s method and then was functionalized by Cys in order to design a targeted 
and controlled drug delivery system. In the next step, β-CD was attached to free amine 
groups of attached Cys moieties on GO surface. DOX was used as a model drug to 
assess the drug-loading and releasing properties and the effect of pH was examined. 
The synthesized graphene-based nanomaterials were structurally and morphologically 
characterized with FT-IR, CHN, Raman, TGA, XRD and FE-SEM techniques. In 
addition, the CD-Cys-GO exhibited remarkably higher loading capacity for DOX than 
Cys-GO and GO. The release of drug was pH-sensitive which would control the release 
in acidic cytoplasm of cancer cells and can be due to the existence of disulfide bonds in 
the structure of this nanocarrier. 
Conclusions: 
In summary, a unique CD-Cys-GO system has been developed. The versatile system 
combines the advantages of graphene, Cys and CD that provides multifunctional and 
inter-reversible anchor sites. The hybrid is found to possess a high drug-loading 
capacity and strong targeting effect. 
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